|
Re: A few comments
|
1
|
Resverlogix Corp.
|
Jan 10, 2017 03:40PM
|
|
Re: ... my letter forwarded to IR...
|
4
|
Resverlogix Corp.
|
Jan 09, 2017 09:33PM
|
|
Re: Resverlogix Announces Presentation at 9th Annual Biotech Showcase Conference in San Francisco, CA
|
2
|
Resverlogix Corp.
|
Jan 06, 2017 03:56PM
|
|
Re: Happy New Year from biOasis Technology inc.
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 05, 2017 04:38PM
|
|
Re: Happy New Year from biOasis Technology inc.
|
|
BIOASIS TECHNOLOGIES INC
|
Jan 02, 2017 02:04PM
|
|
Re: Interesting, Foggy Days
|
4
|
Resverlogix Corp.
|
Dec 30, 2016 07:31AM
|
|
Re: Accuracy... but!!!!...
|
2
|
Resverlogix Corp.
|
Dec 20, 2016 08:15PM
|
|
Re: Accuracy
|
3
|
Resverlogix Corp.
|
Dec 20, 2016 04:37PM
|
|
Re: We lost that one???
|
9
|
Resverlogix Corp.
|
Dec 19, 2016 05:18PM
|
|
Re: A lot of expectations...???
|
2
|
Resverlogix Corp.
|
Dec 16, 2016 02:12PM
|
|
Re: Actions Speak Louder Than Words
|
5
|
Resverlogix Corp.
|
Dec 01, 2016 07:16PM
|
|
Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
|
1
|
Zenith Epigenetics
|
Nov 30, 2016 04:10PM
|
|
Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
|
1
|
Resverlogix Corp.
|
Nov 30, 2016 04:09PM
|
|
Re: Actions Speak Louder Than Words
|
1
|
Resverlogix Corp.
|
Nov 27, 2016 05:31PM
|
|
Re: ... canadian insider report
|
3
|
Resverlogix Corp.
|
Nov 23, 2016 05:59PM
|
|
Re: Resverlogix poster from ASN 2016
|
|
Resverlogix Corp.
|
Nov 21, 2016 04:28PM
|
|
Re: ZCC as opposed to Zenith Epigenetics
|
4
|
Zenith Epigenetics
|
Nov 17, 2016 08:20PM
|
|
Re: Relax Non Zenith Holders
|
1
|
Resverlogix Corp.
|
Nov 16, 2016 05:51PM
|
|
Re: $1.70 close on light volume....
|
1
|
Resverlogix Corp.
|
Nov 15, 2016 05:10PM
|
|
Re: $1.70 close on light volume....
|
|
Resverlogix Corp.
|
Nov 15, 2016 04:27PM
|
